<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Selecting reference values for pulmonary function tests</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Selecting reference values for pulmonary function tests</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Selecting reference values for pulmonary function tests</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David A Kaminsky, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Meredith C McCormack, MD, MHS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Correct interpretation of pulmonary function tests (PFTs) requires the use of appropriate reference values to which the patient's results are compared [<a href="#rid1">1-4</a>].</p><p>Unlike many physiologic parameters for which normal values do not vary with the individual characteristics of the patient, predicted values of pulmonary function depend upon age, sex, and height. Normal values appear to also vary with the patient's race or ethnic background, but the role played by environmental and social determinants of health in this observation is unclear. Therefore, interpretation of PFTs performed for the first time must take multiple factors into consideration. In practice, spirometers and pulmonary function test equipment have software that uses reference equations for calculation of "predicted values," as determined by published studies of large numbers of healthy individuals [<a href="#rid3">3,4</a>].</p><p>The American Thoracic Society (ATS)/European Respiratory Society (ERS) statement on the standardization of spirometry, as well as other ATS guidelines, can be accessed through the ATS web site at <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2F&amp;token=Pby%2FnGkMB8TdW5V6epNUr3SRsNf6YBT3Fr3MIDgZvpZGvZXjM5qSgaeGcxqQwZtc&amp;TOPIC_ID=6971" target="_blank">www.thoracic.org/statements</a>.</p><p>The effects of age, sex, and height on the determination of normal predicted values for interpretation of PFTs, and the use of different predicted reference sets, are reviewed here. We also comment on the effects of weight and race/ethnicity. Finally, we discuss using statistical approaches to define normality. The technique and interpretation of PFTs are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6968.html" rel="external">"Office spirometry"</a> and  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a> and  <a class="medical medical_review" href="/z/d/html/6972.html" rel="external">"Diffusing capacity for carbon monoxide"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EFFECT OF AGE, SEX, HEIGHT, AND WEIGHT</span><span class="headingEndMark"> — </span>PFT results are dependent upon age, sex, and height. Although weight is not a determining factor of lung size or function, body weight may influence lung function results.</p><p class="headingAnchor" id="H3239812616"><span class="h2">Age and sex</span></p><p class="headingAnchor" id="H721864081"><span class="h3">Childhood</span><span class="headingEndMark"> — </span>During childhood up until puberty, lung function increases linearly in proportion to overall growth, which is determined at least in part by age and sex [<a href="#rid5">5,6</a>]. The growth spurt associated with early adolescence is associated with an increase in the rate of overall growth and the rate of increase in lung volumes (and maximal flows) and occurs at slightly different ages in girls and boys  (<a class="graphic graphic_figure graphicRef79707" href="/z/d/graphic/79707.html" rel="external">figure 1A</a> and <a class="graphic graphic_figure graphicRef60080" href="/z/d/graphic/60080.html" rel="external">figure 1B</a>). </p><p>On average, girls reach both their maximal height and their maximal lung volume earlier than boys, but boys achieve larger lung volumes.</p><p>In children, the normal growth of lung function is fast when compared to the rate of changes observed with disease or therapy. As a result, the use of growth charts (looking for trends across percentile lines) most accurately reflects changes that cannot be attributed to growth  (<a class="graphic graphic_figure graphicRef79707 graphicRef60080" href="/z/d/graphic/79707.html" rel="external">figure 1A-B</a>).</p><p class="headingAnchor" id="H3488965258"><span class="h3">Adulthood</span><span class="headingEndMark"> — </span>Cross-sectional spirometric testing of large healthy populations shows a plateau of lung function between the ages of 20 and 30  (<a class="graphic graphic_figure graphicRef54935 graphicRef66761" href="/z/d/graphic/54935.html" rel="external">figure 2A-B</a>). However, longitudinal observation of individuals shows that some have a lung function peak in their early 20s, while others, particularly males, may have the peak in their mid-30s [<a href="#rid7">7</a>].</p><p>Healthy nonsmokers experience a gradual decline in lung function throughout adulthood and old age:</p><p class="bulletIndent1"><span class="glyph">●</span>The forced expiratory volume in one second (FEV<sub>1</sub>) decreases approximately 20 to 30 mL per year [<a href="#rid8">8,9</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The vital capacity (VC) decreases while the residual volume (RV) increases, leaving the total lung capacity intact</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diffusing capacity for carbon monoxide (DLCO, also known as transfer factor) declines linearly with age</p><p></p><p>Among adults, sex during development is an important predictor of lung size. While gender identify must be respected, current recommendations include sex at birth (through puberty) as the basis for predicted values of lung function [<a href="#rid10">10</a>]. The effect of gender-affirming hormonal therapy on lung function is poorly understood. The timing of gender reassignment may impact lung development and should be considered when interpreting results [<a href="#rid10">10-12</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Height</span><span class="headingEndMark"> — </span>Taller persons have a larger frame size and a larger thoracic cage than do shorter persons. Consequently, taller persons have:</p><p class="bulletIndent1"><span class="glyph">●</span>Larger lung volumes</p><p class="bulletIndent1"><span class="glyph">●</span>Higher maximal flow rates</p><p class="bulletIndent1"><span class="glyph">●</span>A greater ability to take up oxygen and carbon monoxide per minute (reflected by a higher diffusing capacity for carbon monoxide [DLCO])</p><p></p><p>As an example, the predicted (mean) vital capacity of a 40-year-old man who is 6 feet 4 inches (193 cm) is six liters, while that of a man who is a foot shorter at 5 feet 4 inches (163 cm) is four liters. Therefore, the accurate measurement, preferably with a stadiometer, of standing height (to the nearest half inch or tenth of a cm, without shoes) is very important in predicting lung function for a particular patient [<a href="#rid3">3</a>]. Technicians should not rely on the stated height. Sitting height is thought to be potentially a more relevant anthropomorphic determinant of lung size, although the contribution of sitting height is highly variable across studies and only accounts for a small proportion of observed differences in lung size among people [<a href="#rid13">13,14</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Weight</span><span class="headingEndMark"> — </span>Body weight is much less important than height when predicting most pulmonary function values; as a result, weight is not included in spirometry prediction equations. However, extremes in weight are associated with changes in lung volumes [<a href="#rid15">15-20</a>]. The body mass index (BMI), which is obtained by dividing the weight (in kilograms) by the square of the height (in meters) (<a class="calc calc_professional" href="/z/d/html/13478.html" rel="external">calculator 1</a>), can be used to quantify obesity. </p><p>The most consistent effect of obesity is reduction in FRC and expiratory reserve volume (ERV)  (<a class="graphic graphic_figure graphicRef55440" href="/z/d/graphic/55440.html" rel="external">figure 3</a>) [<a href="#rid19">19,20</a>]. Mildly reduced lung volumes in patients with a BMI above 30 kg/m<sup>2</sup> may be entirely due to obesity [<a href="#rid18">18</a>]. Further increases in BMI above 30 kg/m<sup>2 </sup>result in additional decreases in FRC and ERV [<a href="#rid20">20</a>]. The effect on spirometry tends to be small. FEV<sub>1</sub> and FVC may be slightly reduced and the ratio is usually preserved, particularly in adults. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults", section on 'Lung volumes'</a>.)</p><p class="headingAnchor" id="H2760858242"><span class="h1">EFFECT OF RACE/ETHNICITY</span><span class="headingEndMark"> — </span>The role of race and ethnicity in reference values for healthy individuals is a controversial topic in pulmonary medicine. The traditional approach used by the standard reference equations (ie, the Global Lung Function Initiative [GLI] and the National Health and Examination Survey [NHANES]) assigns different normal ranges for spirometry according to race and ethnicity. However, this approach assumes that there are true biologic differences in these values among different populations and that these differences are not medically relevant.</p><p>A growing body of evidence has called these assumptions into question:</p><p class="bulletIndent1"><span class="glyph">●</span>In the Atherosclerosis Risk in Communities cohort, the association between survival and lung function was similar between Black and White populations when lung function was interpreted using NHANES III White equations for everyone, but mortality was higher for a given lung function in Black patients when assessed using NHANES III race-specific equations [<a href="#rid21">21</a>]. The authors suggested that because mortality correlated with absolute lung size (forced vital capacity [FVC]) in both populations similarly, use of race-specific equations normalizes the lower lung function of Black patients and leads to an apparent excess mortality when comparing the same percent predicted values. This finding was confirmed in the larger NHANES III population using NHANES III White versus race-specific reference equations [<a href="#rid22">22</a>] and separately by using the GLI-Other versus race-specific GLI reference equations [<a href="#rid23">23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For the broader population, one multiethnic cohort study of 3600 individuals in the United States demonstrated that use of race/ethnicity-based spirometric equations failed to improve the prediction of chronic lower respiratory disease events and mortality compared with race-neutral equations [<a href="#rid24">24</a>]. Similarly, use of race-specific equations based on GLI failed to improve prediction of breathlessness or prognosis in the NHANES III population compared with race-neutral equations (GLI-Other) [<a href="#rid25">25</a>]. Recent data confirm that race-specific reference equations do not improve models of dyspnea nor relate better to quantitative CT measures of lung disease than race-free or race-neutral reference equations [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A separate line of research has more specifically examined underdiagnosis of COPD and COPD severity. Two large cohort studies of patients with or at-risk for COPD (SPIROMICS and COPDGene) have shown that race-neutral equations greatly improve the correlation between spirometry measures and other markers of COPD severity such as the COPD assessment test, modified Medical Research Council dyspnea score, six-minute walk distance, St. George's respiratory questionnaire, and CT measures of emphysema or airway wall thickness [<a href="#rid27">27,28</a>]. These findings were driven by significant underestimation of COPD severity when using race-specific spirometric equations for Black participants.</p><p></p><p class="bulletIndent1">In a population-based cohort study (CARDIA), 6.5 percent of Black males and 6.6 percent of Black females with low-normal lung function (forced expiratory volume in one second [FEV<sub>1</sub>] between 80 percent and 99 percent predicted) based on race-including equations demonstrated emphysema on chest CT, a rate 3.9- and 1.9-fold higher than that seen in White males and females, respectively [<a href="#rid29">29</a>]. The use of race-neutral equations approximately halved these racial differences in undiagnosed emphysema prevalence in males and eliminated the racial differences in females.</p><p></p><p>Together, these data suggest that an unintended clinical consequence of race/ethnicity-specific equations can be to underestimate the severity of pulmonary disease in Black populations. Based on these findings, there have been calls to use one set of normative values rather than race-based equations for standardization of lung function interpretation [<a href="#rid27">27,30</a>].</p><p>The 2022 European Respiratory Society (ERS)/American Thoracic Society (ATS) technical standards acknowledge that interpretation in reference to ancestral grouping may only be useful in certain contexts and that there are trade-offs involved in a population-based rather than a universal standard [<a href="#rid31">31</a>]. Until the use of universal normative values is better studied worldwide and agreed upon, it is reasonable to continue using current reference datasets based on self-reported ancestral origins. The GLI 2022 "race neutral" equation (termed "GLI-Global") is an alternative equation derived as a weighted average of available GLI data from European, African American, North East Asian, and South East Asian racial/ethnic groups; it can be applied universally, but has wider limits of normal than race- and ethnicity-specific equations [<a href="#rid14">14</a>]. The "GLI-Other" equation (2012) can be used similarly if the "GLI-Global" equation is not available. Some have questioned whether the "GLI-Global" equation is truly race-neutral since it is still derived from data from people of different self-reported racial or ethnic backgrounds. It has been suggested that "GLI-Global" more appropriately be considered a "race composite" equation [<a href="#rid32">32</a>]. While this is more accurate, the term "race-neutral" was meant to convey that selection of race is not necessary to employ this equation. Clearly listing the reference equations used to generated predicted values on pulmonary function test reports, as recommended by the ATS/ERS, may help to facilitate mindful interpretation of results.</p><p>A multisociety statement has highlighted the importance of the influence of race/ethnicity on pulmonary function interpretation and the need for more research in this area [<a href="#rid33">33</a>]. Subsequent publications assessing the impact of using race-neutral GLI-Global reference equations compared with using GLI race-specific equations have demonstrated the consequence of diagnosing more Black individuals with respiratory impairment, particularly restrictive pattern by spirometry [<a href="#rid34">34-36</a>]. This effect is expected for the following reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>While differences in absolute values of FEV<sub>1</sub>, forced vital capacity (FVC), lung volumes, diffusing capacity for carbon monoxide (DLCO), and maximal inspiratory and expiratory pressures (MIP and MEP) have been described for different race/ethnic groups, ratios such as FEV<sub>1</sub>/FVC and residual volume (RV)/total lung capacity (TLC) appear to be relatively independent of a patient's background.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For a given absolute value in FEV<sub>1</sub> or FVC, the predicted values for Black individuals are generally lower using a race-specific approach compared with a race-neutral approach. Therefore, the percent of predicted values are generally higher for Black individuals under a race-specific compared with race-neutral approach.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Because obstruction is defined based on FEV<sub>1</sub>/FVC and concern for restriction is based on FEV<sub>1</sub> and FVC  (<a class="graphic graphic_algorithm graphicRef139645" href="/z/d/graphic/139645.html" rel="external">algorithm 1</a>), using race-neutral equations has the greatest impact on the detection threshold for restrictive defects and the classification of disease severity.</p><p></p><p>This effect should be taken into account when using race-neutral equations to help in clinical diagnosis and decision making. For example, one study found that the typical difference in predicted postoperative FEV<sub>1</sub> percent predicted in Black patients using race-neutral equations rather than race-adjusted equations may be sufficient to alter surgical recommendations for lung resection in patients at intermediate risk [<a href="#rid37">37</a>]. Another study has noted that a shift to race-neutral equations would result in higher lung allocation scores for Black patients awaiting lung transplant [<a href="#rid38">38</a>]. Other implications of this interpretative shift on diagnosis, referral, and treatment patterns are under active investigation.</p><p class="headingAnchor" id="H7"><span class="h1">PULMONARY FUNCTION REFERENCE EQUATIONS</span><span class="headingEndMark"> — </span>The patients or population being tested should be considered when applying reference equations. Reference equations should not be used (extrapolated) for patients whose age or height is outside the range of participants included in the reference study. The reference equations that are being used to create predicted values should be included in the pulmonary function report, as outlined in the “Recommendations for a Standardized Pulmonary Function Report” [<a href="#rid39">39</a>].</p><p class="headingAnchor" id="H3137363260"><span class="h2">Spirometry</span><span class="headingEndMark"> — </span>Large reference studies for spirometry have been performed in healthy persons in Europe and North America [<a href="#rid2">2-4</a>]. These studies, National Health and Nutrition Examination Survey (NHANES) III and Global Lung Function Initiative (GLI), have been used to generate reference equations for use in analyzing spirometry results, although additional data are needed for individuals under age 3 and over age 95.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Global Lung Function Initiative</strong> – In 2012, the Global Lung Function Initiative (GLI) published spirometric prediction equations for ages 3 to 95 years for ethnic and geographic groups in 26 countries comprising White American/European, African American, Northeast Asian (Japanese and Korean), and Southeast Asian (Thai and Chinese) individuals. These reference equations are endorsed by the European Respiratory Society, American Thoracic Society, American College of Chest Physicians, the Australian and New Zealand Society of Respiratory Science, Thoracic Society of Australia and New Zealand, and Asian Pacific Society for Respirology. In 2022 the GLI also published a "race-neutral" weighted average of their previously published equations (called "GLI-Global") that can be used universally. The GLI reference equations are recommended for use in North America, as well as in Europe and Australia-New Zealand [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1">Improved data are needed for other population groups, particularly Arab, Indian, Polynesian, African, and Latin American, and other underrepresented groups [<a href="#rid4">4</a>]. Although the latest European Respiratory Society/American Thoracic Society (ERS/ATS) Interpretation Standard [<a href="#rid31">31</a>] recommends using GLI race-specific or "GLI-Other" reference equations, a special workshop convened by the ATS has endorsed using the "GLI-Global" equations for all people, at least until better options are available [<a href="#rid40">40</a>]. As with all recommendations, it will take time for industry to respond to these recommendations and provide GLI-Global as an option in their PFT equipment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>NHANES III</strong> – In 2005, the American Thoracic Society (ATS)-European Respiratory Society (ERS) task force published a listing of pulmonary function reference values and recommendations for interpretative strategies [<a href="#rid3">3</a>]. For the United States, race/ethnically appropriate NHANES III reference equations were recommended for spirometry for those 8 to 80 years old [<a href="#rid2">2</a>]. Specific recommendations were not made for use in Europe at that time. A separate set of equations were recommended for those under eight years [<a href="#rid5">5</a>] but, subsequently, reference equations that can be applied across the spectrum of ages spanning childhood and adulthood were published [<a href="#rid6">6</a>]. For laboratories that are using NHANES III reference equations and choose to maintain continuity, simulation study has demonstrated that GLI and NHANES III are generally concordant with the most notable difference among those at the extremes of height and age [<a href="#rid41">41</a>].</p><p></p><p>Criteria for selecting pulmonary function reference equations include the following [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A population sample (with a wide range of age and height) is preferred to a convenience sample (eg, using volunteers or patients referred to a clinic).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All participants should be never-smokers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Participants should be free of heart disease, lung disease, and chronic respiratory symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The spirometers and test methods should meet current ATS/ERS recommendations. Almost all studies performed prior to 1981 did not conform to ATS standards.</p><p></p><p>Refinement of reference equations may be needed for patients of certain backgrounds. As an example, use of background-specific reference equations may be more accurate for patients in the United States who are of Dominican or Puerto Rican background [<a href="#rid42">42</a>]. In the Hispanic Community Health Study/Study of Latinos (16,415 participants, aged 18 to 74 years), those of Dominican or Puerto Rican background had lower predicted and lower limit of normal values for forced vital capacity (FVC) and forced expiratory volume in one second (FEV<sub>1</sub>), than those of other Hispanic or Mexican American backgrounds [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H2756544172"><span class="h2">Diffusing capacity for carbon monoxide (DLCO) and lung volumes</span><span class="headingEndMark"> — </span>In 2017, the GLI published prediction equations for DLCO, also known as carbon monoxide transfer factor (TLCO) in Europe and other areas of the world [<a href="#rid43">43</a>]. These reference equations apply to White populations who are age 5 to 85 years. The equations are based on data from over 12,000 individuals in 14 countries and 85 percent of the data were from White populations. </p><p>In 2021, the GLI published reference values for lung volumes for individuals of European ancestry between the ages of 5 and 80 years [<a href="#rid44">44</a>]. The equations are derived from 7190 observations in 11 countries and were from White populations only.</p><p>The <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fgli-calculator.ersnet.org%2Findex.html&amp;token=XbaYY7pm0AbJg6Y6tNdiZvQuysb%2FcSqtoraZblwJwlsPtln5e0qjqWdYSA%2FKtpUGncRU4vh9NT9MH0bT2aKDkA%3D%3D&amp;TOPIC_ID=6971" target="_blank">GLI reference equations</a> provide normative values based on a large, internationally representative dataset and expand on the previously existing reference equations that were based on smaller populations [<a href="#rid3">3,45-56</a>]. The GLI plans to validate these reference values in broader populations in future studies. The GLI reference equations for DLCO and lung volumes are endorsed by the ATS, ERS, American College of Chest Physicians, and the Asian Pacific Society of Respirology.</p><p class="headingAnchor" id="H2555345620"><span class="h2">Other pulmonary function tests</span><span class="headingEndMark"> — </span>Reference values for maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) in older adults have also been published [<a href="#rid57">57</a>]. These studies have been limited to a narrower age range and therefore may have limitations in applicability [<a href="#rid53">53</a>].</p><p>Reference values for the six-minute walk distance for adults were published in 1998; this was followed by an ATS guideline on the subject in 2002 [<a href="#rid58">58,59</a>], which was updated by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fcopd%2FFWT-Tech-Std.pdf&amp;token=XPQffIQriyGJU%2FlRHnucYJwBqgvEs0f63Y4bznfYldsLFEd13AhjzcLlVAv1UnV13DOi6fRO8wj9n1RO91ny9vhncyZSvuJ0b%2BWxUR8ce9A%3D&amp;TOPIC_ID=6971" target="_blank">ATS/ERS</a> in 2014 [<a href="#rid60">60</a>]. Sex, age, height, and weight must all be considered when interpreting this test [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">"Overview of pulmonary function testing in adults", section on 'Six-minute walk test'</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">UPPER AND LOWER LIMITS OF NORMALITY</span><span class="headingEndMark"> — </span>The American Thoracic Society (ATS) and European Respiratory Society (ERS) recommended that the <strong>fifth percentile</strong> be used as the lower limit of the normal range (LLN) [<a href="#rid31">31</a>]. By definition, only 5 percent of healthy individuals will have a result below this LLN. Note that the 5<sup>th</sup> percentile occurs at 1.65 standard deviations below the mean, defining a "z-score" of -1.65. Thus, any low value can be remembered easily by having a z-score of less than -1.65.</p><p>Prior to this, a traditional rule of thumb was to use 80 percent of predicted as the LLN for most pulmonary function test results. This standard works fairly well for forced vital capacity (FVC), forced expiratory volume in one second (FEV<sub>1</sub>), diffusing capacity for carbon monoxide (DLCO), and total lung capacity (TLC) in middle-aged adults, but gives a high rate of false positive or false negatives for FEV<sub>1</sub>/FVC, forced expiratory flow (FEF, also called maximum midexpiratory flow) 25 to 75 percent, and maximal respiratory pressures, especially when used for adolescents and adults over the age of 60 [<a href="#rid61">61</a>].</p><p>The use of the LLN rather than a fixed ratio cut off (eg, FEV<sub>1</sub>/FVC 0.7) to define airflow obstruction reduces the misclassification that occurs with a fixed ratio approach. The fixed ratio tends to under-diagnose younger individuals and over-diagnose older individuals with airflow obstruction and the LLN incorporates the changes in FEV<sub>1</sub>/FVC that occur with age and therefore, reduces this misclassification. Categorizing results as "borderline" abnormal if they fall near the LLN is also a useful concept. (See  <a class="medical medical_review" href="/z/d/html/6968.html" rel="external">"Office spirometry", section on 'Ratio of FEV1/FVC'</a>.)</p><p>Of note, use of the LLN to define normal is controversial [<a href="#rid62">62</a>], as some argue that normality should be defined by clinical and not statistical criteria [<a href="#rid63">63</a>], and either the fixed ratio or the LLN may variably correlate better with clinical outcomes [<a href="#rid64">64</a>].</p><p>Static lung volumes and DLCO values are also abnormal when values are above or below a reference standard, so that the normal range for these studies should include both an upper limit of normal (ULN) and an LLN.</p><p>Even when age, sex, height, and race/ethnicity are taken into consideration, the "normal" range for measurements of pulmonary function remains wide. This means that large changes with disease progression or therapy can easily occur while the patient's values remain within the normal range. Therefore, follow-up pulmonary function tests in adults should be compared with the patient's previous (baseline) absolute values, not the predicted values, and interpreted within the clinical context of the patient’s condition [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H3953346987"><span class="h1">ENVIRONMENTAL INFLUENCES</span><span class="headingEndMark"> — </span>Exposure to indoor air pollution, including passive and active exposure to cigarette smoke, and outdoor air pollution can affect lung growth and function [<a href="#rid65">65</a>]. As an example, early childhood exposure to parental smoking is associated with reduced lung function in school age children [<a href="#rid66">66</a>]. All cigarette smoking (starting during the early teens) is associated with an earlier peak in lung function and therefore an earlier onset of decline [<a href="#rid7">7</a>]. In addition, all of the changes due to aging are accelerated in susceptible cigarette smokers.</p><p>Childhood exposure to air pollution has been associated with reduced pulmonary function in a number of studies [<a href="#rid67">67-72</a>]. It is thought that children are particularly susceptible to the effects of poor air quality as lung development continues during childhood [<a href="#rid73">73</a>] and because the higher ventilatory rate and greater likelihood of outdoor exercise result in increased exposure [<a href="#rid67">67</a>]. Both restrictive and obstructive defects have been identified. One cohort study did not find a correlation between air pollution exposure and lung function, but the exposure models used may not have included adjustments for changes in exposure over time [<a href="#rid74">74</a>].</p><p>Other factors related to the social environment, such as socioeconomic status [<a href="#rid13">13,75</a>] and pre- and perinatal nutrition [<a href="#rid76">76</a>], may influence lung development and health.</p><p class="headingAnchor" id="H2043553897"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118218.html" rel="external">"Society guideline links: Pulmonary function testing"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Utility of reference values</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Correct interpretation of PFTs requires comparison of the patient's values with appropriate reference values. The majority of spirometers and pulmonary function equipment use software with reference equations to generate predicted values for each patient. (See <a class="local">'Introduction'</a> above and <a class="local">'Pulmonary function reference equations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reference equations should be listed on the pulmonary function testing report as recommended by the American Thoracic Society (ATS) statement on Recommendations for a Standardized Pulmonary Function Report. (See <a class="local">'Pulmonary function reference equations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reference equations should not be used (extrapolated) for patients outside the range of participants included in the reference study. (See <a class="local">'Pulmonary function reference equations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reference equation parameters</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Age and sex</strong> – During childhood up until puberty, lung function increases linearly in proportion to overall growth, which is determined at least in part by age and sex. Healthy never-smoking adults without exposure to air pollution experience a gradual decline in lung function. The forced expiratory volume in one second (FEV<sub>1</sub>) decreases approximately 30 mL per year. The vital capacity decreases while the residual volume (RV) increases, leaving the total lung capacity intact. The diffusing capacity for carbon monoxide (DLCO) declines linearly with age. (See <a class="local">'Age and sex'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Height</strong> – Taller persons have larger lung volumes, higher maximal flow rates, and a greater ability to take up oxygen and carbon monoxide per minute. Accurate height measurement is important in lung function prediction; technicians should not rely on stated height. (See <a class="local">'Height'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Weight</strong> – Body weight is much less important than height when predicting most pulmonary function values and<strong> is not </strong>included in reference equations. Obesity may result in mildly reduced lung volumes, but this reflects physiologic restriction and should not be corrected for. (See <a class="local">'Weight'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Race and ethnicity</strong> – The traditional approach assigns different normal ranges for spirometry, lung volumes, and other parameters according to race and ethnicity. Accumulating data suggest that an unintended clinical consequence of race/ethnicity-specific equations can be to underestimate the severity of pulmonary disease in some populations. While it is reasonable to continue use of the current reference datasets until universal normative standards are better studied and agreed upon, newer thinking suggests use of the "Global Lung Function Initiative (GLI)-Other" or "GLI-Global" spirometry reference equations for all races/ethnicities. (See <a class="local">'Effect of race/ethnicity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reference standards</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Spirometry</strong> – The GLI reference standards for spirometry are based on data from large, internationally representative populations and are recommended for use in North America, Europe, and Australia-New Zealand. The NHANES III reference standards for spirometry have been used for continuity over time in many labs in North America. Differences between GLI and NHANES III are most notable at the extremes of height and age. (See <a class="local">'Spirometry'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diffusing capacity for carbon monoxide</strong> – The GLI reference equations for DLCO are based on large internationally representative data and provide reference values for White populations from ages 5 to 85 years. (See <a class="local">'Diffusing capacity for carbon monoxide (DLCO) and lung volumes'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lung volumes</strong> – The GLI has published lung volume reference equations for individuals of European ancestry between the ages of 5 and 80 years. These are reference standards for static lung volumes and capacities (eg, total lung capacity, RV, and functional residual capacity  (<a class="graphic graphic_figure graphicRef55440" href="/z/d/graphic/55440.html" rel="external">figure 3</a>)) in White populations. (See <a class="local">'Diffusing capacity for carbon monoxide (DLCO) and lung volumes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interpretation of normal values</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Spirometry</strong> – Airway obstruction should be determined by a FEV<sub>1</sub>/forced vital capacity (FVC) ratio below the age and sex-specific lower limit of normal (LLN), determined from the fifth percentile or z-score of ­1.65. The use of other indices (eg, 0.7) increases the misclassification rates above the accepted 5 percent level. The LLN should also be used for the interpretation of FEV<sub>1</sub>/FVC separately based on current guidelines.(See <a class="local">'Upper and lower limits of normality'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lung volumes and DLCO</strong> – Static lung volumes and DLCO values are abnormal when values are above or below a reference standard, so that the normal range for these studies should include both an upper limit of normal (ULN) and LLN, determined by the upper and lower fifth percentiles (z-score of +1.65 and ­1.65). This approach should replace the traditional rule of thumb of using 80 and 120 percent of predicted as the LLN and ULN for most pulmonary function test values. (See <a class="local">'Upper and lower limits of normality'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Assessing change over time</strong> – Even when age, height, sex, and race/ethnicity are taken into consideration, the "normal" range for measurements of pulmonary function remains wide. It is, therefore, important to compare absolute values in lung function parameters when assessing change over time in a given individual while taking into consideration the natural loss of lung function with age. (See <a class="local">'Upper and lower limits of normality'</a> above.)</p><p></p><p class="headingAnchor" id="H22367502"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Paul Enright, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319.</a></li><li><a class="nounderline abstract_t">Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179.</a></li><li><a class="nounderline abstract_t">Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948.</a></li><li><a class="nounderline abstract_t">Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40:1324.</a></li><li><a class="nounderline abstract_t">Wang X, Dockery DW, Wypij D, et al. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15:75.</a></li><li><a class="nounderline abstract_t">Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008; 177:253.</a></li><li><a class="nounderline abstract_t">Robbins DR, Enright PL, Sherrill DL. Lung function development in young adults: is there a plateau phase? Eur Respir J 1995; 8:768.</a></li><li><a class="nounderline abstract_t">Kerstjens HA, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age and smoking status: facts, figures, and fallacies. Thorax 1997; 52:820.</a></li><li><a class="nounderline abstract_t">Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180:3.</a></li><li><a class="nounderline abstract_t">Haynes JM, Stumbo RW. The Impact of Using Non-Birth Sex on the Interpretation of Spirometry Data in Subjects With Air-Flow Obstruction. Respir Care 2018; 63:215.</a></li><li><a class="nounderline abstract_t">Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev 2012; 33:1.</a></li><li><a class="nounderline abstract_t">Foer D, Rubins D, Almazan A, et al. Gender Reference Use in Spirometry for Transgender Patients. Ann Am Thorac Soc 2021; 18:537.</a></li><li><a class="nounderline abstract_t">Holland R, Bowerman C, Stanojevic S. The Contribution of Anthropometry and Socioeconomic Status to Racial Differences in Measures of Lung Function: A Systematic Review. Chest 2022; 162:635.</a></li><li><a class="nounderline abstract_t">Bowerman C, Bhakta NR, Brazzale D, et al. A Race-neutral Approach to the Interpretation of Lung Function Measurements. Am J Respir Crit Care Med 2023; 207:768.</a></li><li><a class="nounderline abstract_t">Babb TG, Wyrick BL, DeLorey DS, et al. Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest 2008; 134:704.</a></li><li><a class="nounderline abstract_t">Sood A. Altered resting and exercise respiratory physiology in obesity. Clin Chest Med 2009; 30:445.</a></li><li><a class="nounderline abstract_t">Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J 2006; 13:203.</a></li><li><a class="nounderline abstract_t">Sutherland TJ, Goulding A, Grant AM, et al. The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function. Eur Respir J 2008; 32:85.</a></li><li><a class="nounderline abstract_t">Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol (1985) 2010; 108:206.</a></li><li><a class="nounderline abstract_t">Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest 2006; 130:827.</a></li><li><a class="nounderline abstract_t">Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax 2011; 66:49.</a></li><li><a class="nounderline abstract_t">Gaffney AW, McCormick D, Woolhandler S, et al. Prognostic implications of differences in forced vital capacity in black and white US adults: Findings from NHANES III with long-term mortality follow-up. EClinicalMedicine 2021; 39:101073.</a></li><li><a class="nounderline abstract_t">McCormack MC, Balasubramanian A, Matsui EC, et al. Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III. Am J Respir Crit Care Med 2022; 205:723.</a></li><li><a class="nounderline abstract_t">Elmaleh-Sachs A, Balte P, Oelsner EC, et al. Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Am J Respir Crit Care Med 2022; 205:700.</a></li><li><a class="nounderline abstract_t">Ekström M, Mannino D. Research race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007-2012. Respir Res 2022; 23:271.</a></li><li><a class="nounderline abstract_t">Non AL, Bailey B, Bhatt SP, et al. Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes. Chest 2023; 164:1492.</a></li><li><a class="nounderline abstract_t">Baugh AD, Shiboski S, Hansel NN, et al. Reconsidering the Utility of Race-Specific Lung Function Prediction Equations. Am J Respir Crit Care Med 2022; 205:819.</a></li><li><a class="nounderline abstract_t">Regan EA, Lowe ME, Make BJ, et al. Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. Am J Respir Crit Care Med 2024; 209:59.</a></li><li><a class="nounderline abstract_t">Liu GY, Khan SS, Colangelo LA, et al. Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study. Ann Intern Med 2022; 175:1118.</a></li><li><a class="nounderline abstract_t">Schluger NW, Dozor AJ, Jung YEG. Rethinking the Race Adjustment in Pulmonary Function Testing. Ann Am Thorac Soc 2022; 19:353.</a></li><li><a class="nounderline abstract_t">Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022; 60.</a></li><li><a class="nounderline abstract_t">Mannino DM, Townsend MC. Spirometry in 2022: Is a Single Set of Prediction Equations for All the Best Path Forward? Am J Respir Crit Care Med 2023; 207:659.</a></li><li><a class="nounderline abstract_t">Marciniuk DD, Becker EA, Kaminsky DA, et al. Effect of Race and Ethnicity on Pulmonary Function Testing Interpretation: A CHEST/AARC/ATS/CTS Evidence Review and Research Statement. Chest 2023.</a></li><li><a class="nounderline abstract_t">Moffett AT, Bowerman C, Stanojevic S, et al. Global, Race-Neutral Reference Equations and Pulmonary Function Test Interpretation. JAMA Netw Open 2023; 6:e2316174.</a></li><li><a class="nounderline abstract_t">Kanj AN, Scanlon PD, Yadav H, et al. Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population. Am J Respir Crit Care Med 2024; 209:83.</a></li><li><a class="nounderline abstract_t">Connolly MJ, Donohue PA, Palli R, et al. Diagnostic Impact of a Race-Composite Pulmonary Function Test Results Interpretation Strategy. Chest 2023; 164:1290.</a></li><li><a class="nounderline abstract_t">Bonner SN, Lagisetty K, Reddy RM, et al. Clinical Implications of Removing Race-Corrected Pulmonary Function Tests for African American Patients Requiring Surgery for Lung Cancer. JAMA Surg 2023; 158:1061.</a></li><li><a class="nounderline abstract_t">Brems JH, Balasubramanian A, Psoter KJ, et al. Race-Specific Interpretation of Spirometry: Impact on the Lung Allocation Score. Ann Am Thorac Soc 2023; 20:1408.</a></li><li><a class="nounderline abstract_t">Culver BH, Graham BL, Coates AL, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med 2017; 196:1463.</a></li><li><a class="nounderline abstract_t">Bhakta NR, Bime C, Kaminsky DA, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023; 207:978.</a></li><li><a class="nounderline abstract_t">Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J 2016; 48:133.</a></li><li><a class="nounderline abstract_t">LaVange L, Davis SM, Hankinson J, et al. Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos). Am J Respir Crit Care Med 2017; 196:993.</a></li><li><a class="nounderline abstract_t">Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017; 50.</a></li><li><a class="nounderline abstract_t">Hall GL, Filipow N, Ruppel G, et al. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J 2021; 57.</a></li><li><a class="nounderline abstract_t">Knudson RJ, Kaltenborn WT, Knudson DE, Burrows B. The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit. Am Rev Respir Dis 1987; 135:805.</a></li><li><a class="nounderline abstract_t">Miller A, Thornton JC, Warshaw R, et al. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983; 127:270.</a></li><li><a class="nounderline abstract_t">Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123:185.</a></li><li><a class="nounderline abstract_t">Paoletti P, Viegi G, Pistelli G, et al. Reference equations for the single-breath diffusing capacity. A cross-sectional analysis and effect of body size and age. Am Rev Respir Dis 1985; 132:806.</a></li><li><a class="nounderline abstract_t">Roca J, Rodriguez-Roisin R, Cobo E, et al. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis 1990; 141:1026.</a></li><li class="breakAll">Cotes JE, Hall AM. The transfer factor for the lung: normal values in adults. In: Introduction to the definition of normal values for respiratory function in man, Arcangeli P, Cotes JE, Cournand A (Eds), Panminerva Medica, Torino 1970. p.327.</li><li><a class="nounderline abstract_t">Thompson BR, Johns DP, Bailey M, et al. Prediction equations for single breath diffusing capacity (Tlco) in a middle aged caucasian population. Thorax 2008; 63:889.</a></li><li><a class="nounderline abstract_t">Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017; 49.</a></li><li><a class="nounderline abstract_t">Garcia-Rio F, Dorgham A, Pino JM, et al. Lung volume reference values for women and men 65 to 85 years of age. Am J Respir Crit Care Med 2009; 180:1083.</a></li><li><a class="nounderline abstract_t">Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J 1995; 8:492.</a></li><li><a class="nounderline abstract_t">Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 Suppl 16:5.</a></li><li><a class="nounderline abstract_t">Dykstra BJ, Scanlon PD, Kester MM, et al. Lung volumes in 4,774 patients with obstructive lung disease. Chest 1999; 115:68.</a></li><li><a class="nounderline abstract_t">Enright PL, Kronmal RA, Manolio TA, et al. Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group. Am J Respir Crit Care Med 1994; 149:430.</a></li><li><a class="nounderline abstract_t">Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158:1384.</a></li><li><a class="nounderline abstract_t">ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111.</a></li><li><a class="nounderline abstract_t">Singh SJ, Puhan MA, Andrianopoulos V, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014; 44:1447.</a></li><li><a class="nounderline abstract_t">Cerveri I, Corsico AG, Accordini S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC &lt;70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63:1040.</a></li><li><a class="nounderline abstract_t">Smith LJ. The lower limit of normal versus a fixed ratio to assess airflow limitation: will the debate ever end? Eur Respir J 2018; 51.</a></li><li><a class="nounderline abstract_t">Mannino DM. Should we be using statistics to define disease? Thorax 2008; 63:1031.</a></li><li><a class="nounderline abstract_t">Xiong H, Huang Q, Shuai T, et al. Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis. Respir Res 2020; 21:189.</a></li><li><a class="nounderline abstract_t">Raju S, Siddharthan T, McCormack MC. Indoor Air Pollution and Respiratory Health. Clin Chest Med 2020; 41:825.</a></li><li><a class="nounderline abstract_t">Henderson AJ. The effects of tobacco smoke exposure on respiratory health in school-aged children. Paediatr Respir Rev 2008; 9:21.</a></li><li><a class="nounderline abstract_t">Sack CS, Kaufman JD. Air Pollution Levels and Children's Lung Health. How Low Do We Need to Go? Am J Respir Crit Care Med 2016; 193:819.</a></li><li><a class="nounderline abstract_t">Chen Z, Salam MT, Eckel SP, et al. Chronic effects of air pollution on respiratory health in Southern California children: findings from the Southern California Children's Health Study. J Thorac Dis 2015; 7:46.</a></li><li><a class="nounderline abstract_t">Li S, Williams G, Jalaludin B, Baker P. Panel studies of air pollution on children's lung function and respiratory symptoms: a literature review. J Asthma 2012; 49:895.</a></li><li><a class="nounderline abstract_t">Rice MB, Rifas-Shiman SL, Litonjua AA, et al. Lifetime Exposure to Ambient Pollution and Lung Function in Children. Am J Respir Crit Care Med 2016; 193:881.</a></li><li><a class="nounderline abstract_t">Wong SL, Coates AL, To T. Exposure to industrial air pollutant emissions and lung function in children: Canadian Health Measures Survey, 2007 to 2011. Health Rep 2016; 27:3.</a></li><li><a class="nounderline abstract_t">Urman R, McConnell R, Islam T, et al. Associations of children's lung function with ambient air pollution: joint effects of regional and near-roadway pollutants. Thorax 2014; 69:540.</a></li><li><a class="nounderline abstract_t">Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004; 351:1057.</a></li><li><a class="nounderline abstract_t">Fuertes E, Bracher J, Flexeder C, et al. Long-term air pollution exposure and lung function in 15 year-old adolescents living in an urban and rural area in Germany: The GINIplus and LISAplus cohorts. Int J Hyg Environ Health 2015; 218:656.</a></li><li><a class="nounderline abstract_t">Polak M, Szafraniec K, Kozela M, et al. Socioeconomic status and pulmonary function, transition from childhood to adulthood: cross-sectional results from the polish part of the HAPIEE study. BMJ Open 2019; 9:e022638.</a></li><li><a class="nounderline abstract_t">Jordan BK, McEvoy CT. Trajectories of Lung Function in Infants and Children: Setting a Course for Lifelong Lung Health. Pediatrics 2020; 146.</a></li></ol></div><div id="topicVersionRevision">Topic 6971 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16055882" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Standardisation of spirometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9872837" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Spirometric reference values from a sample of the general U.S. population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16264058" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Interpretative strategies for lung function tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22743675" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8474788" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pulmonary function between 6 and 18 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18006882" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Reference ranges for spirometry across all ages: a new approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7656949" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Lung function development in young adults: is there a plateau phase?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9371217" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Decline of FEV1 by age and smoking status: facts, figures, and fallacies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19342411" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29184047" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The Impact of Using Non-Birth Sex on the Interpretation of Spirometry Data in Subjects With Air-Flow Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22240244" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sex differences and sex steroids in lung health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33058733" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Gender Reference Use in Spirometry for Transgender Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35469854" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The Contribution of Anthropometry and Socioeconomic Status to Racial Differences in Measures of Lung Function: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36383197" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A Race-neutral Approach to the Interpretation of Lung Function Measurements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18641101" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Fat distribution and end-expiratory lung volume in lean and obese men and women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19700043" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Altered resting and exercise respiratory physiology in obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16779465" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Altered respiratory physiology in obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18353855" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The effect of adiposity measured by dual-energy X-ray absorptiometry on lung function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19875713" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Physiology of obesity and effects on lung function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16963682" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The effects of body mass index on lung volumes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20980245" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Forced vital capacity, airway obstruction and survival in a general population sample from the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34458707" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prognostic implications of differences in forced vital capacity in black and white US adults: Findings from NHANES III with long-term mortality follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34597248" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34913853" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36182912" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Research race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37507005" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34913855" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Reconsidering the Utility of Race-Specific Lung Function Prediction Equations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37611073" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35849828" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34784493" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Rethinking the Race Adjustment in Pulmonary Function Testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34949706" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : ERS/ATS technical standard on interpretive strategies for routine lung function tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36630683" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Spirometry in 2022: Is a Single Set of Prediction Equations for All the Best Path Forward?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effect of Race and Ethnicity on Pulmonary Function Testing Interpretation: A CHEST/AARC/ATS/CTS Evidence Review and Research Statement</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37261830" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Global, Race-Neutral Reference Equations and Pulmonary Function Test Interpretation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37523681" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Application of Global Lung Function Initiative Global Spirometry Reference Equations across a Large, Multicenter Pulmonary Function Lab Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37421975" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diagnostic Impact of a Race-Composite Pulmonary Function Test Results Interpretation Strategy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37585181" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Clinical Implications of Removing Race-Corrected Pulmonary Function Tests for African American Patients Requiring Surgery for Lung Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37315331" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Race-Specific Interpretation of Spirometry: Impact on the Lung Allocation Score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29192835" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36973004" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27288032" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28613924" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28893868" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33707167" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565929" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6830050" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7235357" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Standardized single breath normal values for carbon monoxide diffusing capacity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3876793" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Reference equations for the single-breath diffusing capacity. A cross-sectional analysis and effect of body size and age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2327636" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2327636" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18390632" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Prediction equations for single breath diffusing capacity (Tlco) in a middle aged caucasian population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28049168" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19745204" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Lung volume reference values for women and men 65 to 85 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7789503" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24576915" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Lung volumes and forced ventilatory flows.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9925064" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Lung volumes in 4,774 patients with obstructive lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8306041" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Respiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9817683" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Reference equations for the six-minute walk in healthy adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12091180" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : ATS statement: guidelines for the six-minute walk test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25359356" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18492741" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Underestimation of airflow obstruction among young adults using FEV1/FVC&lt;70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29599119" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The lower limit of normal versus a fixed ratio to assess airflow limitation: will the debate ever end?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19020267" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Should we be using statistics to define disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32677946" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33153698" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Indoor Air Pollution and Respiratory Health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18280976" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The effects of tobacco smoke exposure on respiratory health in school-aged children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27082532" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Air Pollution Levels and Children's Lung Health. How Low Do We Need to Go?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25694817" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Chronic effects of air pollution on respiratory health in Southern California children: findings from the Southern California Children's Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23016510" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Panel studies of air pollution on children's lung function and respiratory symptoms: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26575800" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Lifetime Exposure to Ambient Pollution and Lung Function in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26885839" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Exposure to industrial air pollutant emissions and lung function in children: Canadian Health Measures Survey, 2007 to 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24253832" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Associations of children's lung function with ambient air pollution: joint effects of regional and near-roadway pollutants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15356303" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The effect of air pollution on lung development from 10 to 18 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26220828" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Long-term air pollution exposure and lung function in 15 year-old adolescents living in an urban and rural area in Germany: The GINIplus and LISAplus cohorts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30782683" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Socioeconomic status and pulmonary function, transition from childhood to adulthood: cross-sectional results from the polish part of the HAPIEE study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32938776" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Trajectories of Lung Function in Infants and Children: Setting a Course for Lifelong Lung Health.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
